<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNA-145 (miR-145) is downregulated in various <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types </plain></SENT>
<SENT sid="1" pm="."><plain>However, its mechanism in inhibiting <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> remains to be elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we found that miR-145 was significantly downregulated in the plasma and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients, and overexpression of miR-145 inhibited cell proliferation, migration and invasion </plain></SENT>
<SENT sid="3" pm="."><plain>To understand the potential mechanism of miR-145 in inhibiting <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e>, we showed that miR-145 blocked the activation of AKT and ERK1/2 pathways, and the expression of HIF-1 and VEGF via directly targeting N-<z:mp ids='MP_0011356'>RAS</z:mp> and IRS1, and VEGF is an important effector for <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Forced expression of N-<z:mp ids='MP_0011356'>RAS</z:mp> and IRS1 restored VEGF expression via transcriptional activation </plain></SENT>
<SENT sid="5" pm="."><plain>MiR-145 also inhibited N-<z:mp ids='MP_0011356'>RAS</z:mp> and IRS1 expression to suppress AKT and ERK1/2 activation, and VEGF expression in mouse xenograft <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>To test the clinical relevance of these results, we used 60 pairs of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues, analyzed the levels of miR-145, N-<z:mp ids='MP_0011356'>RAS</z:mp> and IRS1 expression in these tissues, and found that miR-145 levels were significantly inversely correlated with N-<z:mp ids='MP_0011356'>RAS</z:mp> and IRS1 levels in these <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues, suggesting the important implication of our findings in translational application for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> diagnostics and treatment in the future </plain></SENT>
</text></document>